By proceeding, you agree to our Terms of Use and Privacy Policy.
This 23rd annual meeting continues to set new standards in medical education for these closely linked disease areas and a world class faculty will again present and discuss leading edge developments in their specialities. The meeting is supported and endorsed by 'the Lancet' medical journal and its Editor-in-Chief, Dr Richard Horton.
The event will bring the leaders of the world together at one platform to speak about the disease-prone areas and how to recover from these.
Connect with thought leaders and grow your skillset with interactions and one-on-one discussions. You will also have a chance to indulge in peer conversations.
The event bestows an opportunity to become a part of the leading group of enthusiastic and revolutionary leaders awaiting to transform the healthcare sector.
At the Limits has been leading medical education for over 20 years with world-class live events in Cardiology, Diabetes, Nephrology, Oncology, Multiple Sclerosis and Cell Therapy.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.